Study of Drug Combination on Pharmacokinetics in Healthy Volunteers

NCT02175602 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C Infection

Interventions

DRUG: Escitalopram
DRUG: Sertraline
DRUG: DCV 3DAA FDC
DRUG: BMS-791325

Sponsor

Bristol-Myers Squibb